David R. Healy

512 citations
11 papers · 343 indexed · h-index 9

David R. Healy

11 papers receiving 336 citations

Peers

David R. Healy
Comparison fields: 5 of 69
  • Molecular Biology 153
  • Oncology 91
  • Orthopedics and Sports Medicine 88
  • Pharmacology 83
  • Genetics 64
Replace Kevin Greenslade with:
Kevin Greenslade United Kingdom
Martine Bisson Canada
Zhihua Wen China
WELDON LLOYD United States
Cathy Gomila France
Cara S. Nestlerode United States
F. Del Toro Israel
Zhenyu Shi China
Haruki Odagiri Japan
Su Yang United States
David R. Healy relative to Kevin Greenslade United Kingdom Kevin Greenslade's profile →
Citations per field
00.5×1.5×2.1×
Kevin Greenslade · 1×
Citations per year

Countries citing papers authored by David R. Healy

Since Specialization
Citations

This map shows the geographic impact of David R. Healy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Healy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Healy more than expected).

Fields of papers citing papers by David R. Healy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Healy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Healy. The network helps show where David R. Healy may publish in the future.

Co-authorship network of co-authors of David R. Healy

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Healy. A scholar is included among the top collaborators of David R. Healy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Healy. David R. Healy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 6
2 48
3 9
4 10
5 1
6 20
7 42
8 64
9
Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
11
10 97
11 35

About David R. Healy

David R. Healy is a scholar working on Orthopedics and Sports Medicine, Nephrology and Endocrine and Autonomic Systems, having authored 11 papers that have together received 343 indexed citations. Recurring topics across this work include Bone health and treatments (4 papers), Parathyroid Disorders and Treatments (3 papers) and Bone health and osteoporosis research (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (88 citations), Pharmacology (83 citations) and Nephrology (27 citations). David R. Healy has collaborated with scholars based in United States, Croatia and Germany. Frequent co-authors include Thomas A. Brown, David D. Thompson, Hua Zhu Ke, David T. Crawford, Hollis A. Simmons, Lydia C. Pan, Vishwas Paralkar, Yan Li, Thomas A. Owen and Bruce A. Lefker. Their work appears in journals such as Journal of the American Society of Nephrology, Journal of Pharmacology and Experimental Therapeutics and Journal of Bone and Mineral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026